Q-linea AB (publ)
QLINEA.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$112.22M
Close$
$3.00
82.2% downside
Current Fair Value
82.2% downsideOvervalued by 82.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $112.22 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-27.4 |
| Beta | 0.59 |
| Outstanding Shares | 18,948,752 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -1.28 |
|---|---|
| PEG | 3.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$16.90 M
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$23.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Q-linea AB (publ)
70 employees
CEO: Stuart Gander Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar...